VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot C5624AA: VAERS reports

27 VAERS reports list lot C5624AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2020-02-16 and 2021-09-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
27
Reports
4%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2542%
General / Systemic (non-local)1119%
Dermatological (non-injection-site)814%
Neurological58%
Psychiatric / Neuropsychiatric35%
Allergic / Anaphylactic23%
Gastrointestinal23%
Musculoskeletal23%
Thrombotic / Hematological12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas3
Oregon3
Florida2
California2
Tennessee2
Ohio2
Connecticut1
South Carolina1
Michigan1
New York1
Pennsylvania1
Utah1

Reports by month received

2020-022
2020-031
2020-041
2020-063
2020-071
2020-082
2020-102
2020-112
2021-012
2021-031
2021-063
2021-074
2021-082
2021-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.